HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity

Journal of Leukocyte Biology

Volumn 89, Issue 1, 2011, Pages 149-158

  Lichtfuss, Gregor F ^a,b   Meehan, Aislin C ^b   Cheng, Wan Jung ^a   Cameron, Paul U ^a,b,c   Lewin, Sharon R ^a,b,c   Crowe, Suzanne M ^a,b,c   Jaworowski, Anthony ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

ADCC; CD107a; Signaling

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEIN KINASE ZAP 70;

ADULT; AGE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; BLOOD; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOMETRY; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SEX; SIGNAL TRANSDUCTION;

ADULT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD56; CROSS-LINKING REAGENTS; HIV; HIV INFECTIONS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TIME FACTORS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 79251563155     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0610371     Document Type: Article

References (76)

1. Billadeau, D. D., Leibson, P. J. (2002) ITAMs versus ITIMs: striking a balance during cell regulation. J. Clin. Invest. 109, 161-168.
2. Vivier, E., Nunès, J. A., Vély, F. (2004) Natural killer cell signaling pathways. Science 306, 1517-1519.
3. Zompi, S., Colucci, F. (2005) Anatomy of a murder - signal transduction pathways leading to activation of natural killer cells. Immunol. Lett. 97, 31-39.
4. Perussia, B. (1998) Fc receptors on natural killer cells. Curr. Top. Microbiol. Immunol. 230, 63-88.
5. Hu, P. F., Hultin, L. E., Hultin, P., Hausner, M. A., Hirji, K., Jewett, A., Bonavida, B., Detels, R., Giorgi, J. V. (1995) Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10, 331-340.
6. Weber, K., Meyer, D., Grosse, V., Stoll, M., Schmidt, R. E., Heiken, H. (2000) Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy. Immunobiology 202, 172-178. (Pubitemid 30639247)
7. Meier, U-C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., Klenerman, P., Borrow, P. (2005) Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 79, 12365-12374.
8. Tasca, S., Tambussi, G., Nozza, S., Capiluppi, B., Zocchi, M. R., Soldini, L., Veglia, F., Poli, G., Lazzarin, A., Fortis, C. (2003) Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS 17, 2291-2298. (Pubitemid 38147014)
9. Jewett, A., Cavalcanti, M., Giorgi, J., Bonavida, B. (1997) Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system. J. Immunol. 158, 5492-5500.
10. Tyler, D. S., Stanley, S. D., Nastala, C. A., Austin, A. A., Bartlett, J. A., Stine, K. C., Lyerly, H. K., Bolognesi, D. P., Weinhold, K. J. (1990) Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. J. Immunol. 144, 3375-3384.
11. Fontana, L., Sirianni, M. C., de Sanctis, G., Carbonari, M., Ensoli, B., Aiuti, F. (1986) Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology 171, 425-435.
12. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., Salazar-Mather, T. P. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220.
13. Ahmad, A., Morisset, R., Thomas, R., Menezes, J. (1994) Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 7, 428-437. (Pubitemid 2073220)
14. Baum, L. L., Cassutt, K. J., Knigge, K., Khattri, R., Margolick, J., Rinaldo, C., Kleeberger, C. A., Nishanian, P., Henrard, D. R., Phair, J. (1996) HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J. Immunol. 157, 2168-2173.
15. Ahmad, R., Sindhu, S. T., Toma, E., Morisset, R., Vincelette, J., Menezes, J., Ahmad, A. (2001) Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection. J. Clin. Immunol. 21, 227-233. (Pubitemid 32434310)
16. Gómez-Román, V. R., Patterson, L. J., Venzon, D., Liewehr, D., Aldrich, K., Florese, R., Robert-Guroff, M. (2005) Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J. Immunol. 174, 2185-2189.
17. Forthal, D. N., Landucci, G., Daar, E. S. (2001) Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J. Virol. 75, 6953-6961. (Pubitemid 32641582)
18. Forthal, D. N., Moog, C. (2009) Fc receptor-mediated antiviral antibodies. Curr. Opin. HIV AIDS 4, 388-393.
19. Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., Haynes, B. F., Delfraissy, J-F. (2009) Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23, 897-906.
20. Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., Marx, P. A., Burton, D. R. (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101-104.
21. Bruunsgaard, H., Pedersen, C., Skinhøj, P., Pedersen, B. K. (1997) Clinical progression of HIV infection: role of NK cells. Scand. J. Immunol. 46, 91-95. (Pubitemid 27298868)
22. Sirianni, M. C., Mezzaroma, I., Aiuti, F., Moretta, A. (1994) Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody. Eur. J. Immunol. 24, 1874-1878. (Pubitemid 24237561)
23. De Maria, A., Fogli, M., Costa, P., Murdaca, G., Puppo, F., Mavilio, D., Moretta, A., Moretta, L. (2003) The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33, 2410-2418.
24. Mavilio, D., Benjamin, J., Daucher, M., Lombardo, G., Kottilil, S., Planta, M. A., Marcenaro, E., Bottino, C., Moretta, L., Moretta, A., Fauci, A. S. (2003) Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 100, 15011-15016.
25. Baume, D. M., Robertson, M. J., Levine, H., Manley, T. J., Schow, P. W., Ritz, J. (1992) Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22, 1-6.
26. Mavilio, D., Lombardo, G., Benjamin, J., Kim, D., Follman, D., Marcenaro, E., O'Shea, M. A., Kinter, A., Kovacs, C., Moretta, A., Fauci, A. S. (2005) Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 102, 2886-2891.
27. Jacobs, R., Hintzen, G., Kemper, A., Beul, K., Kempf, S., Behrens, G., Sykora, K. W., Schmidt, R. E. (2001) CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J. Immunol. 31, 3121-3127. (Pubitemid 32994564)
28. Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R., Lockwood, C. J., Schachter, A. D., Park, P. J., Strominger, J. L. (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198, 1201-1212.
29. Carson, W. E., Fehniger, T. A., Caligiuri, M. A. (1997) CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur. J. Immunol. 27, 354-360.
30. Frey, M., Packianathan, N. B., Fehniger, T. A., Ross, M. E., Wang, W. C., Stewart, C. C., Caligiuri, M. A., Evans, S. S. (1998) Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 161, 400-408. (Pubitemid 28285548)
31. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., Caligiuri, M. A. (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97, 3146-3151.
32. Cooper, M. A., Fehniger, T. A., Caligiuri, M. A. (2001) The biology of human natural killer-cell subsets. Trends Immunol. 22, 633-640.
33. Burkhardt, J. K., Hester, S., Argon, Y. (1989) Two proteins targeted to the same lytic granule compartment undergo very different posttranslational processing. Proc. Natl. Acad. Sci. USA 86, 7128-7132.
34. Tschopp, J., Nabholz, M. (1990) Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol. 8, 279-302.
35. Fukuda, M. (1991) Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J. Biol. Chem. 266, 21327-21330.
36. Bryceson, Y. T., March, M. E., Ljunggren, H-G., Long, E. O. (2006) Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214, 73-91. (Pubitemid 44707903)
37. Anderson, P., Caligiuri, M., O'Brien, C., Manley, T., Ritz, J., Schlossman, S. F. (1990) Fc γ receptor type III (CD16) is included in the ζ NK receptor complex expressed by human natural killer cells. Proc. Natl. Acad. Sci. USA 87, 2274-2278. (Pubitemid 20105299)
38. Hibbs, M. L., Selvaraj, P., Carpén, O., Springer, T. A., Kuster, H., Jouvin, M. H., Kinet, J. P. (1989) Mechanisms for regulating expression of membrane isoforms of Fc γ RIII (CD16). Science 246, 1608-1611.
39. Kurosaki, T., Ravetch, J. V. (1989) A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc γ RIII. Nature 342, 805-807.
40. Lanier, L. L., Yu, G., Phillips, J. H. (1989) Co-association of CD3 ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342, 803-805.
41. Ra, C., Jouvin, M. H., Blank, U., Kinet, J. P. (1989) A macrophage Fc γ receptor and the mast cell receptor for IgE share an identical subunit. Nature 341, 752-754. (Pubitemid 19260891)
42. Cone, J. C., Lu, Y., Trevillyan, J. M., Bjorndahl, J. M., Phillips, C. A. (1993) Association of the p56lck protein tyrosine kinase with the Fc γ RIIIA/CD16 complex in human natural killer cells. Eur. J. Immunol. 23, 2488-2497.
43. Salcedo, T. W., Kurosaki, T., Kanakaraj, P., Ravetch, J. V., Perussia, B. (1993) Physical and functional association of p56lck with Fc γ RIIIA (CD16) in natural killer cells. J. Exp. Med. 177, 1475-1480.
44. O'Shea, J. J., Weissman, A. M., Kennedy, I. C., Ortaldo, J. R. (1991) Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the ζ chain. Proc. Natl. Acad. Sci. USA 88, 350-354.
45. Tsang, E., Giannetti, A., Shaw, D., Dinh, M., Tse, J., Gandhi, S., Ho, H., Wang, S., Papp, E., Bradshaw, J. (2008) Molecular mechanism of the Syk activation switch. J. Biol. Chem. 283, 32650-32659.
46. Vivier, E., Morin, P., O'Brien, C., Druker, B., Schlossman, S. F., Anderson, P. (1991) Tyrosine phosphorylation of the Fc γ RIII-(CD16): ζ complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J. Immunol. 146, 206-210.
47. Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., Koup, R. A. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65-78. (Pubitemid 37324571)
48. Alter, G., Malenfant, J. M., Altfeld, M. (2004) CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15-22. (Pubitemid 39626587)
49. zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., Strauss, J., Kasper, B., Nürnberg, G., Becker, C., Maul-Pavicic, A., Beutel, K., Janka, G., Griffiths, G., Ehl, S., Hennies, H. C. (2009) Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am. J. Hum. Genet. 85, 482-492.
50. Bryceson, Y. T., Fauriat, C., Nunes, J. M., Wood, S. M., Björkström, N. K., Long, E. O., Ljunggren, H-G. (2010) Functional analysis of human NK cells by flow cytometry. Methods Mol. Biol. 612, 335-352.
51. Côte, M., Ménager, M. M., Burgess, A., Mahlaoui, N., Picard, C., Schaffner, C., Al-Manjomi, F., Al-Harbi, M., Alangari, A., Le Deist, F., Gennery, A. R., Prince, N., Cariou, A., Nitschke, P., Blank, U., El-Ghazali, G., Ménasché, G., Latour, S., Fischer, A., de Saint Basile, G. (2009) Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J. Clin. Invest. 119, 3765-3773.
52. Stratov, I., Chung, A., Kent, S. J. (2008) Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. J. Virol. 82, 5450-5459.
53. Bryceson, Y. T., Rudd, E., Zheng, C., Edner, J., Ma, D., Wood, S. M., Bechensteen, A. G., Boelens, J. J., Celkan, T., Farah, R. A., Hultenby, K., Winiarski, J., Roche, P. A., Nordenskjöld, M., Henter, J-I., Long, E. O., Ljunggren, H-G. (2007) Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 110, 1906-1915.
54. Overton, W. R. (1988) Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9, 619-626.
55. Hong, H. S., Eberhard, J. M., Keudel, P., Bollmann, B. A., Ballmaier, M., Bhatnagar, N., Zielinska-Skowronek, M., Schmidt, R. E., Meyer-Olson, D. (2010) HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J. Virol. 84, 1183-1188.
56. Eller, M. A., Eller, L. A., Ouma, B. J., Thelian, D., Gonzalez, V. D., Guwatudde, D., McCutchan, F. E., Marovich, M. A., Michael, N. L., de Souza, M. S., Wabwire-Mangen, F., Robb, M. L., Currier, J. R., Sandberg, J. K. (2009) Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J. Acquir. Immune Defic. Syndr. 51, 380-389.
57. Aktas, E., Kucuksezer, U. C., Bilgic, S., Erten, G., Deniz, G. (2009) Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 254, 149-154.
58. Chung, A. W., Rollman, E., Center, R. J., Kent, S. J., Stratov, I. (2009) Rapid degranulation of NK cells following activation by HIV-specific antibodies. J. Immunol. 182, 1202-1210.
59. Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., Matsuda, Y. (1993) Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846-25856.
60. Bonnema, J. D., Karnitz, L. M., Schoon, R. A., Abraham, R. T., Leibson, P. J. (1994) Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180, 1427-1435.
61. Beitz, L. O., Fruman, D. A., Kurosaki, T., Cantley, L. C., Scharenberg, A. M. (1999) SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J. Biol. Chem. 274, 32662-32666.
62. Claus, M., Greil, J., Watzl, C. (2009) Comprehensive analysis of NK cell function in whole blood samples. J. Immunol. Methods 341, 154-164.
63. Wälchli, S., Aasheim, H-C., Skånland, S. S., Spilsberg, B., Torgersen, M. L., Rosendal, K. R., Sandvig, K. (2009) Characterization of clathrin and Syk interaction upon Shiga toxin binding. Cell. Signal. 21, 1161-1168.
64. Hirose, M., Kitano, J., Nakajima, Y., Moriyoshi, K., Yanagi, S., Yamamura, H., Muto, T., Jingami, H., Nakanishi, S. (2004) Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin. J. Biol. Chem. 279, 32308-32315.
65. Brumbaugh, K. M., Binstadt, B. A., Billadeau, D. D., Schoon, R. A., Dick, C. J., Ten, R. M., Leibson, P. J. (1997) Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J. Exp. Med. 186, 1965-1974.
66. Colucci, F., Schweighoffer, E., Tomasello, E., Turner, M., Ortaldo, J. R., Vivier, E., Tybulewicz, V. L. J., Di Santo, J. P. (2002) Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3, 288-294.
67. Ullum, H., Cozzi Lepri, A., Aladdin, H., Katzenstein, T., Victor, J., Phillips, A. N., Gerstoft, J., Skinhøj, P., Klarlund Pedersen, B. (1999) Natural immunity and HIV disease progression. AIDS 13, 557-563.
68. Ahmad, A., Menezes, J. (1996) Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 10, 258-266.
69. Tarazona, R., Casado, J. G., Delarosa, O., Torre-Cisneros, J., Villanueva, J. L., Sanchez, B., Galiani, M. D., Gonzalez, R., Solana, R., Peña, J. (2002) Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J. Clin. Immunol. 22, 176-183.
70. Ironson, G., Balbin, E., Solomon, G., Fahey, J., Klimas, N., Schneiderman, N., Fletcher, M. A. (2001) Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS 15, 2065-2073.
71. Alter, G., Malenfant, J. M., Delabre, R. M., Burgett, N. C., Yu, X. G., Lichterfeld, M., Zaunders, J., Altfeld, M. (2004) Increased natural killer cell activity in viremic HIV-1 infection. J. Immunol. 173, 5305-5311.
72. Richard, J., Sindhu, S., Pham, T. N., Belzile, J-P., Cohen, E. A. (2010) HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115, 1354-1363.
73. Alter, G., Suscovich, T. J., Teigen, N., Meier, A., Streeck, H., Brander, C., Altfeld, M. (2007) Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J. Immunol. 178, 7658-7666.
74. Grzywacz, B., Kataria, N., Verneris, M. R. (2007) CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 21, 356-359, author reply 359. (Pubitemid 46158133)
75. Leeansyah, E., Zhou, J., Paukovics, G., Lewin, S. R., Crowe, S. M., Jaworowski, A. (2010) Decreased NK cell FcRγ in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study. PLoS ONE 5, e9643.
76. Geertsma, M. F., Stevenhagen, A., van Dam, E. M., Nibbering, P. H. (1999) Expression of ζ molecules is decreased in NK cells from HIV-infected patients. FEMS Immunol. Med. Microbiol. 26, 249-257.